Bozcuk et al. [79] developed and externally validated a model combining cancer diagnosis, previous FN, chemotherapy cycle, age, performance status, and lymphocyte count, with an external validation AUROC of 0.78 in patients who did not use G-CSF. Here, CSF3 is linked to cancer.